These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1255 related articles for article (PubMed ID: 32024509)

  • 1. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].
    Zhong FW; Li GX; Zeng L
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
    Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
    Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression.
    Huang X; Chen W; Yan C; Yang R; Chen Q; Xu H; Huang Y
    Biomed Pharmacother; 2019 Oct; 118():109258. PubMed ID: 31545283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.
    Tang W; Yao X; Xia F; Yang M; Chen Z; Zhou B; Liu Q
    Oxid Med Cell Longev; 2018; 2018():7261619. PubMed ID: 30671174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of Ilexhainanoside D and ilexsaponin A
    Zhao W; Xiao M; Yang J; Zhang L; Ba Y; Xu R; Liu Z; Zou H; Yu P; Wu X; Chen X
    Phytomedicine; 2019 Oct; 63():153039. PubMed ID: 31387054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
    Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
    Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 13. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
    Wang L; Jia Z; Wang B; Zhang B
    Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Jiang FY; Yue SR; Tan YY; Tang N; Xu YS; Zhang BJ; Mao YJ; Xue ZS; Lu AP; Liu BC; Wang RR
    Nutrients; 2024 Jun; 16(11):. PubMed ID: 38892715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.
    He Q; Li JK; Li F; Li RG; Zhan GQ; Li G; Du WX; Tan HB
    World J Gastroenterol; 2015 Feb; 21(7):2058-66. PubMed ID: 25717238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats.
    Gong XW; Xu YJ; Yang QH; Liang YJ; Zhang YP; Wang GL; Li YY
    Chin J Integr Med; 2019 Mar; 25(3):216-224. PubMed ID: 29335857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Jiangan-Jiangzhi Pill on Gut Microbiota and Chronic Inflammatory Response in Rats with Non-Alcoholic Fatty Liver.
    Zhao Z; Wang J; Ren W; Bian Y; Wang Y; Wang L; Guo L; Lei J; Jia J; Miao J
    Chem Biodivers; 2022 May; 19(5):e202100987. PubMed ID: 35324083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Gut Microbiota by
    Wu S; Hu R; Nakano H; Chen K; Liu M; He X; Zhang H; He J; Hou DX
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway.
    Shen S; Wang K; Zhi Y; Shen W; Huang L
    Cell Cycle; 2020 Nov; 19(22):3042-3053. PubMed ID: 33121337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.
    Liu JP; Zou WL; Chen SJ; Wei HY; Yin YN; Zou YY; Lu FG
    World J Gastroenterol; 2016 Aug; 22(32):7353-64. PubMed ID: 27621581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.